Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mayne Pharma Group Ltd (MYX.AX)

Mayne Pharma Group Ltd (MYX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mayne Pharma Group Ltd 1538 Main North Road Salisbury South Salisbury SA 5106 AUS

https://www.maynepharma.com P: +61 882092666 F: +61 882810284

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.

Key Statistics

Overview:

Market Capitalization, $K 255,924
Shares Outstanding, K 81,246
Annual Sales, $ 406,510 K
Annual Net Income, $ -93,836 K
% of Institutional Shareholders 18.00%

Growth:

1-Year Return -35.10%
3-Year Return -18.21%
5-Year Return -56.38%
5-Year Revenue Growth -2.30%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -1.19
Annual Dividend & Yield (Fwd) 0.04 (0.00%)
Most Recent Dividend 0.544 on 01/18/23
Next Ex-Dividends Date 01/18/23
Dividend Payable Date 01/27/23
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 01/18/23

MYX.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -22.76%
Return-on-Assets % -8.70%
Profit Margin % -23.08%
Debt/Equity 0.01
Price/Sales 0.59
Price/Book 0.69
Book Value/Share 4.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar